hsa-miR-106a-5p

ncRNA information

ncRNA name

hsa-miR-106a-5p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Diagnosis

Upstream regulatory factors

Not available

Downstream target

ARNT2

Cancer information

Cancer name

Nasopharyngeal Carcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma

Tissue resource

tissue samples were obtained from nasopharyngeal carcinoma patients

nasopharyngeal carcinoma cell lines CNE1

Experiment

None


Institute

the Medical College of Guizhou University

Country

China

Continent

Asia